{"id":"CHEMBL10118","canonicalSmiles":"C[C@@]1(c2ccc(Oc3ccccc3)cc2)OC(=O)N(Nc2ccccc2)C1=O","inchiKey":"PCCSBWNGDMYFCW-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FAMOXADONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07778"],"chEBI":["106738"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL101801","canonicalSmiles":"NC(=O)c1ccc(Nc2nc(N)c(N=O)c(OCC3CCCCC3)n2)cc1","inchiKey":"YBKLJTXDSBEVRV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL101801","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08572"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL107367","canonicalSmiles":"Cc1oc(-c2ccccc2)nc1CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1","inchiKey":"ZZCHHVUQYRMYLW-HKBQPEDESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FARGLITAZAR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Farglitazar","G1-262570","GI-262570","GI-262570X","GI262570X","Gi262570"],"crossReferences":{"PubChem":["144210538"],"Wikipedia":["Farglitazar"]},"count":1,"linkedTargets":{"rows":["ENSG00000132170"],"count":1},"linkedDiseases":{"rows":["EFO_0001422"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1088749","canonicalSmiles":"Nc1ccn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)C[C@@H]3O)[C@@H](CO)O2)c(=O)n1","inchiKey":"LYWWDKIADIGKTH-IDMWBNCISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1088749","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02573"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1088752","canonicalSmiles":"Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1","inchiKey":"KKYABQBFGDZVNQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOSMAPIMOD","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FTX-1821","FTX1821","GSK-AHAB","GSKAHAB","GW-856553X","GW856553","GW856553X","Gw-856553","Losmapimod"],"crossReferences":{"Wikipedia":["Losmapimod"],"drugbank":["DB12270"]},"count":10,"linkedTargets":{"rows":["ENSG00000112062","ENSG00000185386"],"count":2},"linkedDiseases":{"rows":["EFO_0005762","EFO_0003914","EFO_0000685","MONDO_0100096","MONDO_0002009","Orphanet_269","EFO_0000341","EFO_0000319","EFO_0004236","EFO_0005672","Orphanet_309005"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL1091024","canonicalSmiles":"CCC(=O)O[C@H]1[C@H](C)O[C@@H](O[C@@H]2[C@@H](C)O[C@@H](O[C@@H]3[C@@H](OC)[C@H](OC(=O)CC)CC(=O)O[C@H](C)C/C=C/C=C/[C@H](OC(C)=O)[C@H](C)C[C@@H]3CC=O)[C@H](O)[C@H]2N(C)C)C[C@@]1(C)OC(C)=O","inchiKey":"GQNZGCARKRHPOH-RQIKCTSVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIOCAMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Miocamycin","Miokamycin"],"crossReferences":{"Wikipedia":["Miocamycin"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1093423","canonicalSmiles":"CCOc1ccc(Cc2cc([C@@H]3S[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(OC)cc2C)cc1","inchiKey":"WHSOLWOTCHFFBK-ZQGJOIPISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1093423","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12214"]},"childChemblIds":["CHEMBL3781004"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL111659","canonicalSmiles":"C#Cc1cncc([C@@H]2CCCN2C)c1","inchiKey":"NUPUDYKEEJNZRG-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALTINICLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Altinicline","SIB-1508Y","SIB-1765F"],"crossReferences":{"Wikipedia":["Altinicline"]},"childChemblIds":["CHEMBL2146093"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL112","canonicalSmiles":"CC(=O)Nc1ccc(O)cc1","inchiKey":"RZVAJINKPMORJF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ACETAMINOPHEN","yearOfFirstApproval":1968,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abdine","Acephen","Acetaminophen","Alvedon","Angiers","Calpol","Calpol six plus","Calpol six plus fastmelts","Child lemsip","Cupanol","Dafalgan","Datril","Disprol","Disprol infant","Disprol jnr","Disprol paed","Fennings","Galpamol","Hedex","Infadrops","Infants' feverall","Injectapap","Junior parapaed","Mandanol","Medinol","Medinol for children","Medinol over 6","Medinol under 6","Medised plain","Miradol","Neopap","Ofirmev","Paldesic","Panadol","Panadol actifast","Panadol actifast solb","Panadol advan","Panadol jnr","Panadol oa","Panaleve","Panaleve 6 plus","Paracetamol","Paramin","Parapaed jnr","Parapaed six plus","Paravict","Perfalgan","Phenaphen","Placidex","Rimadol","Salzone","Tixymol","Tramil 500","Tylenol"],"synonyms":["Acetaminophen","Apap","NSC-109028","NSC-3991","Paracetamol"],"crossReferences":{"DailyMed":["acetaminophen"],"PubChem":["104171293","11112253","11114188","124882135","144209128","144210420","170466797","17390068","174007306","26747171","56422763"],"TG-GATEs":["1"],"Wikipedia":["Paracetamol"],"drugbank":["DB00316"],"chEBI":["46195"]},"count":89,"approvedIndications":["EFO_0005856","EFO_0003821","HP_0001945","EFO_0010072","EFO_0007328","HP_0100607","HP_0003418","MONDO_0002258","EFO_0003843","EFO_0007214"],"linkedTargets":{"rows":["ENSG00000117480","ENSG00000073756","ENSG00000196689","ENSG00000095303"],"count":4},"linkedDiseases":{"rows":["EFO_0007486","EFO_0007444","EFO_0000249","HP_0000175","HP_0012228","EFO_0005952","HP_0011868","EFO_0003964","EFO_1000831","EFO_0003931","EFO_0008585","EFO_0000096","EFO_0002690","EFO_0000339","EFO_1001366","EFO_0004616","EFO_1000652","EFO_0005762","HP_0012532","HP_0012076","EFO_0010072","EFO_0004197","EFO_0000384","EFO_0000546","MP_0001914","EFO_0009260","EFO_0003957","EFO_0000574","EFO_0004209","EFO_0007328","EFO_0001378","HP_0100607","EFO_0000516","MONDO_0002258","EFO_0005672","EFO_0003943","MONDO_0018373","EFO_0003086","HP_0002373","MONDO_0021117","HP_0000545","MONDO_0007254","EFO_0003882","EFO_0004143","EFO_1001092","EFO_1000249","EFO_0000616","EFO_0000772","EFO_0005774","EFO_0004210","EFO_0009816","EFO_0004269","EFO_1001757","EFO_0001645","EFO_0000403","HP_0011110","EFO_0003929","EFO_0000618","HP_0003418","EFO_0001073","EFO_0003843","HP_0002315","EFO_0004599","EFO_0000537","EFO_0003885","EFO_1001412","EFO_1001460","EFO_0000764","EFO_0004273","EFO_0007359","MONDO_0043510","EFO_0002756","EFO_0004710","EFO_0009615","MONDO_0024647","EFO_1001139","EFO_1000905","HP_0000989","EFO_0005592","HP_0001643","EFO_0000540","EFO_0003829","HP_0002018","Orphanet_365","EFO_0002506","EFO_0000544","EFO_0004253","EFO_1001898","EFO_0000389","EFO_1000786","HP_0003419","HP_0008419","EFO_1000749","EFO_1001250","EFO_0005761","EFO_1001476","EFO_0001074","EFO_0000220","EFO_0005856","EFO_0003821","EFO_0002508","HP_0100806","MONDO_0100096","EFO_0000731","HP_0030833","EFO_0001359","MONDO_0044917","EFO_0004888","EFO_0001360","EFO_0000668","EFO_0002970","Orphanet_232","EFO_0009267","MONDO_0024355","EFO_1000783","EFO_1001216","EFO_0002460","HP_0002013","EFO_0000685","EFO_0004329","HP_0001945","EFO_0000677","EFO_0003060","EFO_0007214","EFO_0000311","EFO_0010282","EFO_0001068","EFO_0000095","EFO_1001891","EFO_0003766","EFO_0005611","HP_0000023"],"count":132},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1968 and has 10 approved and 79 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1162175","canonicalSmiles":"CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21","inchiKey":"NXHAXEBZOXCDKD-XIXRRVGJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REGRELOR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Regrelor"],"crossReferences":{"drugbank":["DB05553"]},"childChemblIds":["CHEMBL261244"],"linkedTargets":{"rows":["ENSG00000169313"],"count":1},"linkedDiseases":{"rows":["EFO_0001645","EFO_0000319"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL117287","canonicalSmiles":"COCCCN1CCC(NC(=O)c2cc(Cl)c(N)c3c2OCC3)CC1","inchiKey":"ZPMNHBXQOOVQJL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRUCALOPRIDE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Resolor"],"synonyms":["Prucalopride","R-093877"],"crossReferences":{"DailyMed":["prucalopride%20succinate"],"PubChem":["170466188","174006285"],"drugbank":["DB06480"]},"childChemblIds":["CHEMBL2105748"],"count":4,"approvedIndications":["HP_0002019"],"linkedTargets":{"rows":["ENSG00000164270"],"count":1},"linkedDiseases":{"rows":["EFO_0003948","HP_0002590","EFO_0001421","HP_0012450","MONDO_0004567","EFO_1000948","HP_0002015","HP_0002019"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for constipation and has 3 investigational indications."}
{"id":"CHEMBL117391","canonicalSmiles":"C[N+](C)([O-])CCNc1ccc(NCC[N+](C)(C)[O-])c2c1C(=O)c1c(O)ccc(O)c1C2=O","inchiKey":"YZBAXVICWUUHGG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BANOXANTRONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Banoxantrone"],"crossReferences":{"PubChem":["174007442"],"drugbank":["DB04975"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL117658","canonicalSmiles":"CCCC[C@@H](C=O)NC(=O)OC1(Cc2ccccc2)CCCC1","inchiKey":"ONABDOMWRCXLPX-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL117658","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07593"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1178725","canonicalSmiles":"CC(C)Oc1cccc(CC(=O)N2CCC[C@](CC[N+]34CCC(c5ccccc5)(CC3)CC4)(c3ccc(Cl)c(Cl)c3)C2)c1","inchiKey":"RPDFDSQFBCJTDY-GAQXSTBRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NOLPITANTIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nolpitantium"],"childChemblIds":["CHEMBL2105831","CHEMBL38763"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1187319","canonicalSmiles":"O=C(N[C@H]1CCCNC1)c1n[nH]cc1NC(=O)c1c(F)cccc1F","inchiKey":"KOMNQBZWMCFDTQ-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1187319","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08141"]},"childChemblIds":["CHEMBL498659"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1192519","canonicalSmiles":"O=C(O)CN1C(=O)[C@@H](N[C@@H](CCc2ccccc2)C(=O)O)CCc2ccccc21","inchiKey":"MADRIHWFJGRSBP-ROUUACIJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENAZEPRILAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benazeprilat","CGS 14831"],"crossReferences":{"drugbank":["DB14125"],"chEBI":["88200"]},"childChemblIds":["CHEMBL543766"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200357","canonicalSmiles":"CO[C@@]1(NC(=O)C(C(=O)[O-])c2ccc(O)cc2)C(=O)N2C(C(=O)[O-])=C(CSc3nnnn3C)CO[C@@H]21.[Na+].[Na+]","inchiKey":"GRIXGZQULWMCLU-HUTAOCTPSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MOXALACTAM DISODIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL74632","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Moxam","Shiomarin"],"synonyms":["LY-127935","Latamoxef sodium","Moxalactam disodium"],"crossReferences":{"PubChem":["144204344","170465353"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200381","canonicalSmiles":"Cl.N=C(N)NCCC[C@H](N)C(=O)O","inchiKey":"KWTQSFXGGICVPE-WCCKRBBISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARGININE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["R-gene 10"],"synonyms":["Arginine hydrochloride","L-arginine hydrochloride","NSC-203450","NSC-7914"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1200541","canonicalSmiles":"CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)Cc1ccccc1Cl)Cc1ccccc1Cl.[Cl-].[Cl-]","inchiKey":"DXUUXWKFVDVHIK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMBENONIUM CHLORIDE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1652","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mytelase"],"synonyms":["Ambenonium chloride"],"crossReferences":{"PubChem":["144205583","170465386"],"chEBI":["2628"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1956."}
{"id":"CHEMBL1200542","canonicalSmiles":"CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"VPGRYOFKCNULNK-ACXQXYJUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DESOXYCORTICOSTERONE ACETATE","yearOfFirstApproval":1939,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Doca","Percorten"],"synonyms":["Deoxycorticosterone acetate","Deoxycortone","Desoxycorticosterone acetate","Desoxycortone","Desoxycortone acetate","NSC-9567"],"crossReferences":{"PubChem":["144204427","170465334","29215003","56422097","855662"],"drugbank":["DB06780"],"chEBI":["34671"]},"linkedTargets":{"rows":["ENSG00000151623"],"count":1},"linkedDiseases":{"rows":["HP_0002619","EFO_1001434"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1939."}
{"id":"CHEMBL1200585","canonicalSmiles":"C[C@]12C/C(=C/O)C(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O","inchiKey":"ICMWWNHDUZJFDW-DHODBPELSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OXYMETHOLONE","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anadrol","Anadrol-50","Anapolon 50"],"synonyms":["Anadrol","CI-406","HMD","Oximetholone","Oxymetholone"],"crossReferences":{"DailyMed":["oxymetholone"],"PubChem":["144204682","144207269","170465403","17388810"],"Wikipedia":["Oxymetholone"],"drugbank":["DB06412"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1972. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200724","canonicalSmiles":"CN[C@@H](C)[C@@H](O)c1ccccc1.Cl","inchiKey":"BALXUFOVQVENIU-KXNXZCPBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PSEUDOEPHEDRINE HYDROCHLORIDE","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1590","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Actifed","Contac","Dimotane plus","Dimotane plus l.a.","Galpseud","Galpseud plus","Novafed","Otrivine mu-cron","Pseudoephedrine hydrochloride","Pseudophed","Sinutab","Sudafed","Sudafed 12 hour","Sudafed 12 hr decongest","Sudafed 24 hour","Sudafed plus","Sudafed-sa"],"synonyms":["NSC-106567","NSC-33634","Pseudoephedrine hydrochloride"],"crossReferences":{"DailyMed":["pseudoephedrine%20hydrochloride"],"PubChem":["50086711","544025"],"chEBI":["8604"]},"count":9,"approvedIndications":["EFO_0005854","EFO_0007486","HP_0012735","EFO_0003821","EFO_0007328","EFO_0003843","EFO_0007214","EFO_0003785","EFO_0003956"],"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0007486","HP_0012735","EFO_0003821","MONDO_0024290","EFO_0007328","EFO_0003843","EFO_0007214","EFO_0003956","EFO_0003785"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and has 9 approved indications."}
{"id":"CHEMBL1200745","canonicalSmiles":"C=CCOc1ccccc1OCC(O)CNC(C)C.Cl","inchiKey":"COAJXCLTPGGDAJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXPRENOLOL HYDROCHLORIDE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL546","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Apsolox","Laracor","Oxyprenix excel 160","Paritane","Slow-pren","Slow-trasicor","Trasicor","Trasicor ret"],"synonyms":["BA-39,089","BA-39089","Oxprenolol hydrochloride"],"crossReferences":{"PubChem":["144204107","170464995","56463641"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1983."}
{"id":"CHEMBL1200995","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(CSc3nc(=O)c(O)nn3C)CS[C@H]12)c1csc(N)n1.[Na+]","inchiKey":"YOBPSXOHCHDCMU-VKZZUTNHSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTRIAXONE SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL161","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ceftriaxone","Rocephin"],"synonyms":["Ro-139904"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201057","canonicalSmiles":"CC1(C)C[C@@H]1C(=O)N/C(=C\\CCCCSC[C@H](N)C(=O)O)C(=O)[O-].[Na+]","inchiKey":"QXPBTTUOVWMPJN-QBNHLFMHSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CILASTATIN SODIUM","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL766","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cilastatin sodium","Cilastatin sodium salt","MK-791"],"crossReferences":{"DailyMed":["cilastatin%20sodium"],"PubChem":["144206357","49732002"],"chEBI":["59511"]},"count":5,"approvedIndications":["EFO_0003106","HP_0100806","EFO_0003103","EFO_0000544","EFO_0000465"],"linkedTargets":{"rows":["ENSG00000015413"],"count":1},"linkedDiseases":{"rows":["EFO_0003106","HP_0100806","EFO_0003103","EFO_0000544","EFO_0000465"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 5 approved indications."}
{"id":"CHEMBL1201058","canonicalSmiles":"CC(=O)[O-].[K+]","inchiKey":"SCVFZCLFOSHCOH-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM ACETATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Potassium acetate"],"synonyms":["E261","Potassium acetate"],"crossReferences":{"DailyMed":["potassium%20acetate"],"DrugCentral":["4217"],"Wikipedia":["Potassium_acetate"],"drugbank":["DB14498"],"chEBI":["32029"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1201242","canonicalSmiles":"CC(C)NCCCC1(C(N)=O)c2ccccc2-c2ccccc21","inchiKey":"UCEWGESNIULAGX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDECAINIDE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Indecainide"],"crossReferences":{"PubChem":["170465192"],"Wikipedia":["Indecainide"],"drugbank":["DB00192"]},"childChemblIds":["CHEMBL1200341"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1989."}
{"id":"CHEMBL1201360","canonicalSmiles":"C[C@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl","inchiKey":"LEHFPXVYPMWYQD-XHIJKXOTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HALOBETASOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Halobetasol"],"crossReferences":{"Wikipedia":["Ulobetasol"],"drugbank":["DB00596"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201485","drugType":"Small molecule","blackBoxWarning":true,"name":"SOYBEAN OIL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Intralipid","Liposyn Iii","Nutrilipid","Soyacal","Travamulsion"],"synonyms":["Glycine max seed oil","Soybean oil"],"count":16,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 16 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201486","drugType":"Small molecule","blackBoxWarning":true,"name":"QUINIDINE POLYGALACTURONATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cardioquin"],"synonyms":["Quinidine polygalacturonate"],"count":1,"approvedIndications":["EFO_0004269"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000196876","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000007314","ENSG00000136531","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_0004269"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for cardiac arrhythmia. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201489","drugType":"Protein","blackBoxWarning":false,"name":"SERACTIDE ACETATE","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acthar gel-synthetic"],"synonyms":["Seractide acetate"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1978."}
{"id":"CHEMBL1201867","drugType":"Unknown","blackBoxWarning":true,"name":"FERUMOXYTOL","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Feraheme","Rienso"],"synonyms":["CODE 7228","CODE-7228","Ferumoxytol","RIENSO"],"crossReferences":{"DailyMed":["ferumoxytol"],"DrugCentral":["5204"],"Wikipedia":["Iron(II,III)_oxide"]},"count":6,"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1213369","canonicalSmiles":"O=C1C=C(Nc2nnn[nH]2)CCC1","inchiKey":"REZXFQGPXQJVJG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1213369","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07865"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1229846","canonicalSmiles":"OCCOc1ccccc1","inchiKey":"QCDWFXQBSFUVSP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENOXYETHANOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Phenoxyethanol"],"crossReferences":{"PubChem":["144204553","144209309","144211159","170465671","17389580","26752767","26752768","56463731"],"Wikipedia":["Phenoxyethanol"],"drugbank":["DB11304"],"chEBI":["64275"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1230513","canonicalSmiles":"O=C(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)COP(=O)(O)O","inchiKey":"BIRSGZKFKXLSJQ-SQOUGZDYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230513","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02076"],"chEBI":["48928"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230674","canonicalSmiles":"Cn1cnc2c(O)nc(N)nc21","inchiKey":"UUWJNBOCAPUTBK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"9-Methylguanine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["9-Methylguanine"],"crossReferences":{"PubChem":["144210126"],"drugbank":["DB02489"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231240","canonicalSmiles":"O=C1N=C(O)NC(=O)[C@@]1(c1ccccc1)N1CCC(CCO)CC1","inchiKey":"IPBPOBHSNJFRFT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231240","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03622"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232586","canonicalSmiles":"COCCOCCOCCOCCO","inchiKey":"ZNYRFEPBTVGZDN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232586","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144207946"],"drugbank":["DB04332"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233","canonicalSmiles":"CCCC(C)(COC(N)=O)COC(=O)NC(C)C","inchiKey":"OFZCIYFFPZCNJE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARISOPRODOL","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"],"classes":["Misuse"],"year":2007},"tradeNames":["Carisoma","Carisoprodol","Rela","Soma"],"synonyms":["Carisoprodol","Carisoprodol civ","NSC-172124"],"crossReferences":{"DailyMed":["carisoprodol"],"PubChem":["124879774","144203673","144207821","170465436","17389120","174006896","26752303","50105222","56424069","85230985","855912","90341406"],"Wikipedia":["Carisoprodol"],"drugbank":["DB00395"],"chEBI":["3419"]},"count":2,"approvedIndications":["EFO_0003843"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and is indicated for pain and has 1 investigational indication. It was withdrawn in European Union  in 2007 due to Misuse."}
{"id":"CHEMBL1234599","canonicalSmiles":"CC(=O)N1CCC[C@H]1C(=O)O","inchiKey":"GNMSLDIYJOSUSW-LURJTMIESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234599","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["24839128"],"drugbank":["DB03360"],"chEBI":["21560"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234658","canonicalSmiles":"Cc1ccc(O)c([N+](=O)[O-])c1","inchiKey":"SYDNSSSQVSOXTN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234658","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208131"],"drugbank":["DB04110"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235423","canonicalSmiles":"O=C1[C@@H](NS(=O)(=O)c2cc3ncccc3s2)CCN1Cc1cc2ccncc2[nH]1","inchiKey":"PLXOQMHGHDZMSX-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235423","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08426"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236188","canonicalSmiles":"NC(=S)c1ccc[n+]([C@@H]2O[C@H](CO[P@@](=O)([O-])O[P@](=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](OP(=O)(O)O)[C@@H]3O)[C@@H](O)[C@H]2O)c1","inchiKey":"OJNFDOAQUXJWED-NNYOXOHSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236188","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01763"]},"childChemblIds":["CHEMBL1255844"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236539","canonicalSmiles":"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@@H]4O","inchiKey":"PBCZSGKMGDDXIJ-HQCWYSJUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"7-Hydroxystaurosporine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["7-Hydroxystaurosporine"],"crossReferences":{"PubChem":["499504"],"drugbank":["DB01933"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1251","canonicalSmiles":"CC/N=C(\\NCC)NCCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCCN/C(=N/CC)NCC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc1cccnc1)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(C)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O","inchiKey":"GJNXBNATEDXMAK-PFLSVRRQSA-N","drugType":"Protein","blackBoxWarning":false,"name":"GANIRELIX ACETATE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ganirelix Acetate Injection","Ganirelix acetate","Orgalutran"],"synonyms":["Ganirelix","Ganirelix acetate","RS-26306","RS-26306-298"],"crossReferences":{"DailyMed":["ganirelix%20acetate"],"Wikipedia":["Ganirelix"],"drugbank":["DB06785"]},"count":4,"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000545","EFO_1000645","EFO_1000859","EFO_0000660"],"count":4},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 4 investigational indications."}
{"id":"CHEMBL1255738","canonicalSmiles":"NC(N)=NCc1cccc(I)c1.O=S(=O)(O)O","inchiKey":"NMHJRGCKGFRFAQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"M-Iodobenzylguanidine Hemisulfate","maximumClinicalTrialPhase":0,"parentId":"CHEMBL818","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["M-Iodobenzylguanidine Hemisulfate"],"crossReferences":{"PubChem":["56463643"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1276138","canonicalSmiles":"O=C(c1ccc2nonc2c1)N1CCCCC1","inchiKey":"XFVRBYKKGGDPAJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FARAMPATOR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CX 691","CX-691","CX691","Farampator","ORG 24448","ORG-24448","SCH-900460"],"crossReferences":{"drugbank":["DB15012"]},"count":3,"linkedTargets":{"rows":["ENSG00000125675","ENSG00000120251","ENSG00000155511","ENSG00000152578"],"count":4},"linkedDiseases":{"rows":["MONDO_0002050","MONDO_0002009","EFO_0000692"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1374738","canonicalSmiles":"O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1","inchiKey":"PLHJDBGFXBMTGZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1374738","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["50085998","8139923"],"drugbank":["DB00614"],"chEBI":["5195"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL141","canonicalSmiles":"Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1","inchiKey":"JTEGQNOMFQHVDC-NKWVEPMBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LAMIVUDINE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Epivir","Epivir-hbv","Lamivudine","Zeffix"],"synonyms":["BCH 189, (-)-","Epivir","GR 109714X","GR-109714X","Lamivudine"],"crossReferences":{"DailyMed":["lamivudine"],"PubChem":["29215254","49681736"],"Wikipedia":["Lamivudine"],"drugbank":["DB00709"],"chEBI":["63577"]},"childChemblIds":["CHEMBL537885"],"count":18,"approvedIndications":["MP_0001845","EFO_0000544","EFO_0000764","EFO_0000180","EFO_0004197","EFO_0000763","EFO_0004239"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 7 approved and 11 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1410743","canonicalSmiles":"CC1OC(C)OC(C)O1","inchiKey":"SQYNKIJPMDEDEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PARALDEHYDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Paral"],"synonyms":["FEMA NO. 4010","NSC-9799","Paracetaldehyde","Paraldehyde"],"crossReferences":{"PubChem":["144205161","144211616","170465660","29215288","50109849"],"Wikipedia":["Paraldehyde"],"drugbank":["DB09117"],"chEBI":["27909"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1449","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](C(=O)O)c3ccsc3)C(=O)N2[C@H]1C(=O)O","inchiKey":"OHKOGUYZJXTSFX-KZFFXBSXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TICARCILLIN","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ticarcillin"],"crossReferences":{"Wikipedia":["Ticarcillin"],"drugbank":["DB01607"],"chEBI":["9587"]},"childChemblIds":["CHEMBL3989647","CHEMBL3765148","CHEMBL1200855"],"count":4,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and is indicated for bacterial disease and has 3 investigational indications."}
{"id":"CHEMBL146554","canonicalSmiles":"CC(C)C(=O)C(=O)O","inchiKey":"QHKABHOOEWYVLI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-Oxoisovalerate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Oxoisovalerate","alpha-Ketoisovalerate","alpha-Oxoisovalerate"],"crossReferences":{"Wikipedia":["Alpha-Ketoisovaleric_acid"],"drugbank":["DB04074"],"chEBI":["16530"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1507567","canonicalSmiles":"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3C(=O)C[C@@]21C","inchiKey":"MOVRKLZUVNCBIP-RFZYENFJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1507567","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["49645975"],"drugbank":["DB14646"],"chEBI":["34655"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1603","canonicalSmiles":"CN(N=O)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"ZSJLQEPLLKMAKR-GKHCUFPYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STREPTOZOSIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144209057","144213291","170464827"],"drugbank":["DB00428"],"chEBI":["9288"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1614710","canonicalSmiles":"O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12","inchiKey":"FGTCROZDHDSNIO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OSI-930","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OSI-930","Osi 930","Osi-930"],"crossReferences":{"PubChem":["137276003"],"drugbank":["DB05913"]},"count":1,"linkedTargets":{"rows":["ENSG00000128052","ENSG00000102755","ENSG00000037280","ENSG00000157404"],"count":4},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1619785","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)OC1OC(=O)c2ccccc21","inchiKey":"SOROUYSPFADXSN-SUWVAFIASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALAMPICILLIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Talampicillin"],"crossReferences":{"drugbank":["DB13814"],"chEBI":["9391"]},"childChemblIds":["CHEMBL1411731"],"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bacterial disease."}
{"id":"CHEMBL164660","canonicalSmiles":"O=c1ccc2cc3ccoc3cc2o1","inchiKey":"ZCCUUQDIBDJBTK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PSORALEN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-404562","Psoralen"],"crossReferences":{"PubChem":["11113270","26754320","50085967"],"Wikipedia":["Psoralen"],"chEBI":["27616"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1660","canonicalSmiles":"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\\C=C\\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C","inchiKey":"WDZCUPBHRAEYDL-GZAUEHORSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIFAPENTINE","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Priftin"],"synonyms":["ANTIBIOTIC DL-473IT","DL-473","KTC-1","MDL 473","MDL-473","R-77-3","R-773","Rifapentine"],"crossReferences":{"DailyMed":["rifapentine"],"PubChem":["144205988"],"Wikipedia":["Rifapentine"],"drugbank":["DB01201"],"chEBI":["45304"]},"count":4,"approvedIndications":["Orphanet_3389"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for tuberculosis and has 3 investigational indications."}
{"id":"CHEMBL1712923","canonicalSmiles":"Nc1nc(N)nc(-c2cc(Cl)ccc2Cl)n1.O=C(O)/C=C\\C(=O)O","inchiKey":"PJLVTVAIERNDEQ-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IRSOGLADINE MALEATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL136497","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Irsogladine maleate","MN-1695"],"crossReferences":{"PubChem":["144205339","170465947","49681596"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1742997","drugType":"Antibody","blackBoxWarning":false,"name":"CANTUZUMAB MERTANSINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cantuzumab mertansine","HUC242-DM1","SB-408075"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1743004","drugType":"Antibody","blackBoxWarning":false,"name":"CRENEZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Crenezumab","MABT-5102A","MABT5102A","RG-7412","RG7412"],"count":1,"linkedTargets":{"rows":["ENSG00000142192"],"count":1},"linkedDiseases":{"rows":["EFO_0000249"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1743019","drugType":"Antibody","blackBoxWarning":false,"name":"FIGITUMUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["871","CP-751","CP-751,871","CP-751871","Figitumumab"],"count":14,"linkedTargets":{"rows":["ENSG00000140443"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0006859","MONDO_0021117","MONDO_0007254","EFO_0003060","EFO_0000311","EFO_0000174","EFO_0000702","EFO_0000673","EFO_0004142","EFO_0001378","EFO_0000707","EFO_0003050","EFO_0000691"],"count":14},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 14 investigational indications."}
{"id":"CHEMBL180517","canonicalSmiles":"CCc1c2cc(O)ccc2nn1-c1ccc(O)cc1","inchiKey":"XBMVVMYGKMGLJX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL180517","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07712"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1880349","canonicalSmiles":"OCC1OC(O)CC(O)C1O","inchiKey":"PMMURAAUARKVCB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-DEOXY-D-GLUCOSE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-deoxy-d-glucose","BA 2758","BA-2758","NSC-15193"],"crossReferences":{"PubChem":["174006875","93576859"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1892210","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12.O.O","inchiKey":"SRRPEXWCHWWJOC-JEKSYDDFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1892210","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1517","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205264","144210996","50105559"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1899801","canonicalSmiles":"FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F","inchiKey":"NJCBUSHGCBERSK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERFLENAPENT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FC41-12 (PERFLENAPENT/PERFLISOPENT MIXTURE)","NVX-108","Nvx-108","Perflenapent"],"crossReferences":{"PubChem":["144205977","50112673"],"drugbank":["DB11625"],"chEBI":["39428"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1908350","canonicalSmiles":"CCCC(=O)O[C@H]1[C@H](C)O[C@@H](O[C@@H]2[C@@H](C)O[C@@H](O[C@@H]3[C@@H](OC)[C@H](O)CC(=O)O[C@H](C)C/C=C/C=C/[C@H](O)[C@H](C)C[C@@H]3CC=O)[C@H](O)[C@H]2N(C)C)C[C@@]1(C)OC(=O)CC","inchiKey":"VYWWNRMSAPEJLS-MDWYKHENSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROKITAMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rokitamycin"],"crossReferences":{"drugbank":["DB13409"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1921847","canonicalSmiles":"Cc1cc(C)cc([C@@H]2CCCN2Cc2ccc(Oc3ccc(C(N)=O)cc3F)cc2)c1","inchiKey":"ZHPMYDSXGRRERG-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATICAPRANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aticaprant","CERC-501","Cerc-501","JNJ-67953964-AAA","JSPA-0658","JSPA0658","Jnj-67953964","LY-2456302","LY2456302","Ly2456302"],"crossReferences":{"drugbank":["DB12341"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1922673","canonicalSmiles":"CCOc1ccc(-c2ccc(Cn3c(CC(C)(C)C(=O)[O-])c(SC(C)(C)C)c4cc(OCc5ccc(C)cn5)ccc43)cc2)cn1.[Na+]","inchiKey":"NOJNFULGOQGBKB-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"FIBOFLAPON SODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1922660","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AM-803 SODIUM","Fiboflapon sodium","GSK-2190915A","GSK2190915A","SODIUM SALT"],"count":3,"linkedTargets":{"rows":["ENSG00000132965"],"count":1},"linkedDiseases":{"rows":["EFO_0000289","EFO_0000270","Orphanet_586","EFO_1001348"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1946186","canonicalSmiles":"CN1[C@H]2CC[C@@H]1C[C@H](OC1c3ccccc3CCc3ccccc31)C2","inchiKey":"ZWPODSUQWXAZNC-PMOLBWCYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEPTROPINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Deptropine"],"crossReferences":{"drugbank":["DB13466"],"chEBI":["50189"]},"childChemblIds":["CHEMBL2107603"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1951575","canonicalSmiles":"CC(C)(C)NC(=O)c1ccc(Oc2cc(F)c(CC(=O)O)cc2Cl)c(NS(=O)(=O)c2ccc(C3CC3)cc2Cl)c1","inchiKey":"PFWVGKROPKKEDW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VIDUPIPRANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 853","AMG-853","Vidupiprant"],"crossReferences":{"drugbank":["DB12272"]},"count":1,"linkedTargets":{"rows":["ENSG00000168229","ENSG00000183134"],"count":2},"linkedDiseases":{"rows":["EFO_0000270"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL199441","canonicalSmiles":"O=C(O)c1ccc(-c2ccccc2OC(F)(F)F)o1","inchiKey":"PSLFQKRPFOCZHR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL199441","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07304"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL200495","canonicalSmiles":"CCCc1c(OCCCOc2ccc3c(ccn3CC(=O)O)c2)ccc2c(C(F)(F)F)noc12","inchiKey":"TWVYNPULGKGJOS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL200495","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07053"]},"childChemblIds":["CHEMBL120554"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL20461","canonicalSmiles":"OB(O)CCc1ccccc1","inchiKey":"VPRUMANMDWQMNF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENETHYLBORONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Phenylethyl Boronic Acid","Phenethylboronic Acid"],"crossReferences":{"drugbank":["DB01963"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL204656","canonicalSmiles":"COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C(C)C","inchiKey":"JUZYLCPPVHEVSV-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELVITEGRAVIR","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vitekta"],"synonyms":["Elvitegravir","GS-9137","JTK-303"],"crossReferences":{"DailyMed":["elvitegravir"],"Wikipedia":["Elvitegravir"],"drugbank":["DB09101"],"chEBI":["72289"]},"count":5,"approvedIndications":["EFO_0000764","EFO_0000180","EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL2068724","canonicalSmiles":"CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]","inchiKey":"BUVGWDNTAWHSKI-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"ACAMPROSATE CALCIUM","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201293","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acamprosate calcium","Campral","Campral ec"],"synonyms":["Acamprosate calcium"],"crossReferences":{"DailyMed":["acamprosate%20calcium"],"PubChem":["144206019","144212923"],"chEBI":["51042"]},"count":1,"linkedTargets":{"rows":["ENSG00000183454","ENSG00000273079","ENSG00000116032","ENSG00000109158","ENSG00000145863","ENSG00000011677","ENSG00000187730","ENSG00000151834","ENSG00000145864","ENSG00000198785","ENSG00000166206","ENSG00000022355","ENSG00000102287","ENSG00000182256","ENSG00000161509","ENSG00000105464","ENSG00000094755","ENSG00000268089","ENSG00000163285","ENSG00000113327","ENSG00000176884","ENSG00000186297","ENSG00000163288"],"count":23},"linkedDiseases":{"rows":["EFO_0003829"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2004 and has 1 investigational indication."}
{"id":"CHEMBL2103792","canonicalSmiles":"Cc1cn([C@H]2C[C@H](O)[C@@H](COP(O)(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3CO)O2)c(=O)[nH]c1=O","inchiKey":"OKYYOKGIPDRZJA-CPSXWDTOSA-N","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"AGATOLIMOD","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Agatolimod","PF-3512676"],"childChemblIds":["CHEMBL2103793"],"count":1,"linkedTargets":{"rows":["ENSG00000239732"],"count":1},"linkedDiseases":{"rows":["EFO_0009441","EFO_0000616","EFO_0003869","MONDO_0019465","EFO_0007444","EFO_0000756","EFO_0000681","EFO_0002913","EFO_0000403","EFO_0000313","EFO_1001469","EFO_0005952","EFO_0003060","EFO_0000311","HP_0100806","EFO_0000096","EFO_0001068","MONDO_0000544","EFO_0000095","EFO_0000764","EFO_0000191","EFO_0000574","EFO_1001051","MONDO_0018906","EFO_1000550"],"count":25},"description":"Oligonucleotide drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2103809","canonicalSmiles":"CCOc1ccccc1O[C@@H](c1ccccc1)[C@@H]1CNCCO1.O=C(O)CCC(=O)O","inchiKey":"YXZTUOWIYOESGT-HLRBRJAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESREBOXETINE SUCCINATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL180101","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Esreboxetine succinate","PNU-165442G"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103862","canonicalSmiles":"O=C(c1ccc(CN2CCOCC2)cc1)N1CCN(C2CC2)CC1","inchiKey":"BGBVSGSIXIIREO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BAVISANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bavisant","JNJ-31001074"],"crossReferences":{"drugbank":["DB12299"]},"childChemblIds":["CHEMBL3577957","CHEMBL2105715"],"count":2,"linkedTargets":{"rows":["ENSG00000101180"],"count":1},"linkedDiseases":{"rows":["EFO_0003888","EFO_0003829"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105685","canonicalSmiles":"Cl.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1","inchiKey":"IKQFRXPMBGQJGE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMUVATINIB HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2103851","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amuvatinib hydrochloride","HPK56","MP-470.HCL","MP470.HCL"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105715","canonicalSmiles":"Cl.Cl.O.O=C(c1ccc(CN2CCOCC2)cc1)N1CCN(C2CC2)CC1","inchiKey":"BLFBQJUVAGIUBL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BAVISANT DIHYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2103862","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BEN-2001","Bavisant dihydrochloride","Bavisant dihydrochloride monohydrate","Ben-2001","JNJ-31001074-AAC"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2105745","canonicalSmiles":"O=C(CCCc1ccccc1)OCC(COC(=O)CCCc1ccccc1)OC(=O)CCCc1ccccc1","inchiKey":"ZSDBFLMJVAGKOU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCEROL PHENYLBUTYRATE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ravicti"],"synonyms":["Glycerol phenylbutyrate","HPN-100","HPN100"],"crossReferences":{"DailyMed":["glycerol%20phenylbutyrate"],"drugbank":["DB08909"]},"count":4,"approvedIndications":["Orphanet_79167","MONDO_0004739"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for disorder of urea cycle metabolism and ammonia detoxification and urea cycle disorder and has 2 investigational indications."}
{"id":"CHEMBL2105786","canonicalSmiles":"CC/C(=C(/c1ccc(OCCN(C)C)cc1)c1cccc(O)c1)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"GTJXPMSTODOYNP-BTKVJIOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DROLOXIFENE CITRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL487","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Droloxifene citrate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105907","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N=[N+]=[N-])c3ccccc3)C(=O)N2[C@H]1C(=O)O","inchiKey":"ODFHGIPNGIAMDK-NJBDSQKTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZIDOCILLIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azidocillin","BRL 2534","SPC 297 D"],"crossReferences":{"drugbank":["DB08795"],"chEBI":["51758"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107744","canonicalSmiles":"Cc1cc(C)cc(NC(=O)Cc2ccc(OC(C)(C)C(=O)[O-])cc2)c1.[Na+]","inchiKey":"SWDPIHPGORBMFR-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"EFAPROXIRAL SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL18901","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Efaproxiral sodium","RSR13 SODIUM"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107816","canonicalSmiles":"[223Ra+2].[Cl-].[Cl-]","inchiKey":"RWRDJVNMSZYMDV-SIUYXFDKSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"RADIUM RA 223 DICHLORIDE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2111187","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bay 88-8223","Xofigo"],"synonyms":["BAY 88-8223","BAY-88-8223","BAY88-8223","Radium (223ra) dichloride","Radium chloride ra-223","Radium ra 223 dichloride","Radium ra-223 dichloride","Radium-223 chloride"],"crossReferences":{"DailyMed":["radium%20ra-223%20dichloride"],"drugbank":["DB08913"],"chEBI":["74895"]},"count":9,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 9 investigational indications."}
{"id":"CHEMBL2107913","drugType":"Protein","blackBoxWarning":false,"name":"OPEBACAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bactericidal permeability-increasing protein opebacan","Opebacan","RBPI-21"],"count":1,"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108350","drugType":"Protein","blackBoxWarning":false,"name":"CONESTAT ALFA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Complement c1 esterase inhibitor","Conestat alfa"],"crossReferences":{"DrugCentral":["5152"]},"count":4,"approvedIndications":["Orphanet_91378"],"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and is indicated for hereditary angioedema and has 3 investigational indications."}
{"id":"CHEMBL2108451","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"DEXTRAN 70","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Aquasite"],"synonyms":["Dextran 70"],"count":3,"description":"Oligosaccharide drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108475","drugType":"Antibody","blackBoxWarning":false,"name":"PRILIXIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Centara"],"synonyms":["CEN 000029","CM-MT412","MT-412","Priliximab"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108623","drugType":"Unknown","blackBoxWarning":false,"name":"MILK THISTLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Milk thistle","Milk thistle silymarin","Silybum marianum","Silybum marianum dry fruit","Silybum marianum dry fruit extract","Silybum marianum extract","Silybum marianum fruit","Silybum marianum fruit extract","Silybum marianum seed","Silybum marianum seed extract"],"count":7,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL2108938","drugType":"Small molecule","blackBoxWarning":false,"name":"CADEXOMER IODINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Iodoflex","Iodosorb"],"synonyms":["Cadexomer iodine"],"count":1,"approvedIndications":["HP_0200042"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for skin ulcer."}
{"id":"CHEMBL2109005","drugType":"Small molecule","blackBoxWarning":false,"name":"CASTOR OIL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Castor oil","Castor oil, aromatic","FEMA NO. 2263","Oleum ricini","Ricinus communis fibre oil","Ricinus communis oil","Ricinus communis seed oil"],"count":2,"approvedIndications":["HP_0002019"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for constipation and has 1 investigational indication."}
{"id":"CHEMBL2109137","drugType":"Protein","blackBoxWarning":false,"name":"MOROCTOCOG ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Moroctocog alfa"],"crossReferences":{"DrugCentral":["5166"]},"count":1,"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109634","drugType":"Antibody","blackBoxWarning":false,"name":"ONCOLYSIN S","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ONCOLYSIN S"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109647","drugType":"Antibody","blackBoxWarning":false,"name":"REGN-728","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["REGN-728"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2110609","canonicalSmiles":"CCCCCCCCCCCC[N+](CCO)(CCO)Cc1ccccc1","inchiKey":"BTAFSOGRDASALR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZOXONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13565"]},"childChemblIds":["CHEMBL2104255"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2110783","canonicalSmiles":"CC(C)(CO)[C@@H](O)C(=O)NCCCC(=O)O","inchiKey":"SBBDHANTMHIRGW-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HOPANTENIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hopantenic acid"],"crossReferences":{"drugbank":["DB14044"]},"childChemblIds":["CHEMBL4303660","CHEMBL2106027"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2110786","canonicalSmiles":"[SrH2]","inchiKey":"KJNGJIPPQOFCSK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STRONTIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Strontium"],"childChemblIds":["CHEMBL2106034"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2110805","canonicalSmiles":"CC[N+](C)(C)C(C)CC(c1ccccc1)c1ccccc1","inchiKey":"JEJBJBKVPOWOQK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMEPRONIUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Emepronium"],"crossReferences":{"drugbank":["DB13505"]},"childChemblIds":["CHEMBL2106122"],"count":2,"approvedIndications":["HP_0000020","HP_0000103"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for urinary incontinence and polyuria."}
{"id":"CHEMBL2111083","canonicalSmiles":"CN(C)C(=O)COc1ccc2c(c1)C[C@@H](NC[C@H](O)c1ccc(O)c(CCO)c1)CC2","inchiKey":"OANCEOSLKSTLTA-REWPJTCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEDORADRINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bedoradrine"],"crossReferences":{"drugbank":["DB05590"]},"childChemblIds":["CHEMBL2218893"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0000270","EFO_0008590","EFO_0000341"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2111092","canonicalSmiles":"O=S(=O)(O)CCCS(=O)(=O)O","inchiKey":"MGNVWUDMMXZUDI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPRODISATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eprodisate"],"crossReferences":{"drugbank":["DB06405"]},"childChemblIds":["CHEMBL2107338"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2111164","canonicalSmiles":"O=[N+]([O-])OCCN(CCO[N+](=O)[O-])CCO[N+](=O)[O-]","inchiKey":"HWKQNAWCHQMZHK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROLNITRATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Trolnitrate"],"crossReferences":{"PubChem":["144206882"],"drugbank":["DB13719"]},"childChemblIds":["CHEMBL3989711"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2165709","canonicalSmiles":"C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12.Cl","inchiKey":"LBSFSRMTJJPTCW-VJAUXQICSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUINIDINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1294","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Quinidine HCl"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL21731","canonicalSmiles":"CNCCCC12CCC(c3ccccc31)c1ccccc12","inchiKey":"QSLMDECMDJKHMQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MAPROTILINE","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BA-34,276 FREE BASE","BA-34,276 [AS HYDROCHLORIDE]","BA-34276 FREE BASE","Maprotiline"],"crossReferences":{"DailyMed":["maprotiline%20hydrochloride"],"PubChem":["104171192","11111502","11112599","11113802","124880790","124880792","144203751","170464778","26751977","50085871","50104649","90341780"],"Wikipedia":["Maprotiline"],"drugbank":["DB00934"],"chEBI":["6690"]},"childChemblIds":["CHEMBL1237135"],"count":5,"approvedIndications":["EFO_0003761"],"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050","HP_0000726","EFO_0003761","EFO_0005230","EFO_0000692","EFO_0000519"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1980 and is indicated for unipolar depression and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL219586","canonicalSmiles":"Cc1nc(-c2ccc(C(F)(F)F)cc2)sc1C(=O)NCc1ccc(OC(C)(C)C(=O)O)cc1","inchiKey":"ILUPZUOBHCUBKB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GW590735","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW590735","Gw590735"],"crossReferences":{"drugbank":["DB07215"]},"count":1,"linkedTargets":{"rows":["ENSG00000186951"],"count":1},"linkedDiseases":{"rows":["Orphanet_309005"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL220529","canonicalSmiles":"C[C@@H](C(=O)N1CCOCC1)N1CC[C@H](NS(=O)(=O)c2cc3cc(Cl)ccc3s2)C1=O","inchiKey":"LTJNKFUIOOJXNJ-WFASDCNBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL220529","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07843"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL223824","canonicalSmiles":"Nc1cccc(CN2C(=O)N(Cc3cccc(N)c3)[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@H]2Cc2ccccc2)c1","inchiKey":"KYRSNWPSSXSNEP-ZRTHHSRSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOZENAVIR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DMP-450","Mozenavir"],"crossReferences":{"drugbank":["DB02102"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2251727","canonicalSmiles":"CCN=C=S","inchiKey":"HBNYJWAFDZLWRS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYL ISOTHIOCYANATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ethyl isothiocyanate","FEMA NO. 4420","NSC-84212"],"crossReferences":{"chEBI":["85098"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL225210","canonicalSmiles":"N[C@H]1CN(CCc2ccc3c(c2)OCO3)C(=O)C[C@@H]1c1cc(F)c(F)cc1F","inchiKey":"DIRIFWIKLRTNMB-DYVFJYSZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL225210","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07830"]},"childChemblIds":["CHEMBL538090"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL236777","canonicalSmiles":"Nc1nc(CCc2ccc3cc[nH]c3c2)cc(=O)[nH]1","inchiKey":"VRAZIAJSKFRSIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL236777","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07535"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL239508","canonicalSmiles":"O=Cc1cc(=O)oc2cc(OCc3cccc(Cl)c3)ccc12","inchiKey":"ZOCADHRNWNJARU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL239508","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07512"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL24944","canonicalSmiles":"O=C(Nc1ccc(Br)cc1)c1cc(Br)cc(Br)c1O","inchiKey":"KVSKGMLNBAPGKH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIBROMSALAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":["Tuasol 100"],"synonyms":["ET-394","Tribromsalan"],"crossReferences":{"PubChem":["144205253","144209640","144213540","170465542","29215431"],"chEBI":["127105"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States."}
{"id":"CHEMBL258940","canonicalSmiles":"CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1","inchiKey":"FTFRZXFNZVCRSK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FALNIDAMOL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIBX 1382","BIBX-1382","Bibx 1382","Bibx-1382","Falnidamol"],"crossReferences":{"PubChem":["124892343","26755049"],"drugbank":["DB12966"]},"childChemblIds":["CHEMBL2136050"],"count":1,"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL259571","canonicalSmiles":"CC(C)c1c(O)cc(/C=C/c2ccccc2)cc1O","inchiKey":"ZISJNXNHJRQYJO-CMDGGOBGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAPINAROF","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-2894512","GSK2894512","Tapinarof","WBI-1001","Wbi-1001"],"crossReferences":{"drugbank":["DB06083"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL267936","canonicalSmiles":"CNC1(C)C2CCC(C2)C1(C)C","inchiKey":"IMYZQPCYWPFTAG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MECAMYLAMINE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Mecamylamine"],"crossReferences":{"DailyMed":["mecamylamine%20hydrochloride"],"PubChem":["104171190","144203749","170465225","26755706","50111169","90341710"],"drugbank":["DB00657"],"chEBI":["6706"]},"childChemblIds":["CHEMBL1237082"],"count":8,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000117971","ENSG00000080644"],"count":2},"linkedDiseases":{"rows":["EFO_0009606","GO_0007568","MONDO_0002050","EFO_0001365","MONDO_0002009","EFO_0003758","EFO_0003768","EFO_0009321","EFO_0000537","EFO_0003829"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1956 and is indicated for hypertension and has 7 investigational indications."}
{"id":"CHEMBL269277","canonicalSmiles":"C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12","inchiKey":"QGJZLNKBHJESQX-FZFNOLFKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETULINIC ACID","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALS-357","Betulinic acid","NSC-113090","NSC-677578"],"crossReferences":{"PubChem":["26725276","26756781"],"Wikipedia":["Betulinic_acid"],"drugbank":["DB12480"],"chEBI":["3087"]},"childChemblIds":["CHEMBL1783811","CHEMBL3601028"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL273124","canonicalSmiles":"COc1nc(C(Cl)(Cl)Cl)c(Cl)c(OC)c1Cl","inchiKey":"DZVPGIORVGSQMC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENCLOMEDINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-338720","Penclomedine"],"crossReferences":{"PubChem":["460965"],"drugbank":["DB12987"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL274070","canonicalSmiles":"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(N)cccc3nc2-1","inchiKey":"FUXVKZWTXQUGMW-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"9-AMINOCAMPTOTHECIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["9-aminocamptothecin","NSC-603071"],"crossReferences":{"PubChem":["26725257","483848"],"drugbank":["DB12515"],"chEBI":["80755"]},"count":11,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL279014","canonicalSmiles":"CCN(CC)CCNc1ccc(C)c2sc3ccccc3c(=O)c12","inchiKey":"FBQPGGIHOFZRGH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUCANTHONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lucanthone"],"crossReferences":{"drugbank":["DB04967"],"chEBI":["51052"]},"childChemblIds":["CHEMBL2007389"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL282468","canonicalSmiles":"C[N+](C)(C)CCO.[Cl-]","inchiKey":"SGMZJAMFUVOLNK-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHOLINE CHLORIDE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Choline chloride","FEMA NO. 4500","NSC-402838"],"crossReferences":{"PubChem":["144207690","26748816"],"Wikipedia":["Choline_chloride"],"chEBI":["133341"]},"childChemblIds":["CHEMBL2095207"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 3 investigational indications."}
{"id":"CHEMBL287038","canonicalSmiles":"CN(C)CCCNC(=O)c1cccc2c(N)c3ccccc3nc12","inchiKey":"VNWAULKXOPRJEL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL287038","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02842"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL298312","canonicalSmiles":"Cc1cccc(O)c1","inchiKey":"RLSSMJSEOOYNOY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METACRESOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Metacresol"],"crossReferences":{"PubChem":["144209139","144212962","26754464","26754465","29215287"],"Wikipedia":["M-Cresol"],"drugbank":["DB01776"],"chEBI":["17231"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL30","canonicalSmiles":"CN/C(=N/CCSCc1nc[nH]c1C)NC#N","inchiKey":"AQIXAKUUQRKLND-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIMETIDINE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acid-eze","Acitak 200","Acitak 400","Acitak 800","Brumetadina","Cimetidine","Dyspamet","Galenamet","Kentamet","Peptimax 200","Peptimax 400","Peptimax 800","Tagadine","Tagamet","Tagamet 100","Tagamet hb","Tagamet hb 200","Ultec","Valmagen","Zita"],"synonyms":["Cimetidine","NSC-335308","SKF-92334"],"crossReferences":{"DailyMed":["cimetidine"],"PubChem":["104171130","11113773","11533056","144203657","144208358","170464651","17389962","26747359","26751957","460110","50104629","56462993","90341189"],"TG-GATEs":["35"],"Wikipedia":["Cimetidine"],"drugbank":["DB00501"],"chEBI":["3699"]},"childChemblIds":["CHEMBL1201051"],"count":9,"approvedIndications":["HP_0004398","EFO_0003948"],"linkedTargets":{"rows":["ENSG00000113749"],"count":1},"linkedDiseases":{"rows":["EFO_0003948","MP_0001914","HP_0004398","EFO_1001892","HP_0002239","MONDO_0011962","EFO_0000253","EFO_0000341","EFO_0000274","MONDO_0043839"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and is indicated for gastroesophageal reflux disease and peptic ulcer and has 7 investigational indications."}
{"id":"CHEMBL301829","canonicalSmiles":"O=C(O)c1ccc(C(F)(F)F)cc1-c1ccc2c(c1)OC[C@H](Cc1ccccc1)[C@H]2O","inchiKey":"NZQDWKCNBOELAI-KSFYIVLOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CP-195543","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-195,543","Cp-195,543","Cp-195543"],"crossReferences":{"drugbank":["DB13053"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3039113","canonicalSmiles":"CCNC(=O)CC[C@H](N)C(=O)O","inchiKey":"DATAGRPVKZEWHA-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THEANINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-theanine","NSC-21308","Theanine"],"crossReferences":{"drugbank":["DB12444"],"chEBI":["17394"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3087323","canonicalSmiles":"Cc1ncc([N+](=O)[O-])n1CCNS(N)(=O)=O","inchiKey":"AVSMSXHPIYIKIJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DTP-348","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DTP348","Dtp-348","Dtp348"],"crossReferences":{"drugbank":["DB12741"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3099551","canonicalSmiles":"C[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CCCC[C@@H]1CCSS1)C(=O)O","inchiKey":"MQXRTCVZPIHBLD-TUAOUCFPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CMX-2043","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cmx-2043"],"crossReferences":{"drugbank":["DB12795"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3125457","canonicalSmiles":"[2H]C([2H])(c1ccc(OCC)cc1)c1cc([C@]2([2H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)ccc1Cl","inchiKey":"JVHXJTBJCFBINQ-MIAUTHJWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3125457","maximumClinicalTrialPhase":0,"parentId":"CHEMBL429910","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3183086","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3183086","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2097081","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144203865","170464889"],"chEBI":["9179"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3185786","canonicalSmiles":"CCCCCCCC[Si](OCC)(OCC)OCC","inchiKey":"MSRJTTSHWYDFIU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3185786","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144213951"],"drugbank":["DB11267"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3260567","canonicalSmiles":"Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1","inchiKey":"FJCDSQATIJKQKA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VACTOSERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TEW-7197","Tew 7197","Tew-7197","Vactosertib"],"crossReferences":{"drugbank":["DB15310"]},"childChemblIds":["CHEMBL3260908"],"count":9,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL330546","canonicalSmiles":"C[C@H](O)C(=O)O","inchiKey":"JVTAAEKCZFNVCJ-REOHCLBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-LACTIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-Lactic Acid"],"crossReferences":{"Wikipedia":["Lactic_acid"],"drugbank":["DB14475"],"chEBI":["422"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL331378","canonicalSmiles":"C[C@H](CSC(=O)c1ccccc1)C(=O)N1C[C@@H](Sc2ccccc2)C[C@H]1C(=O)O","inchiKey":"IAIDUHCBNLFXEF-MNEFBYGVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOFENOPRIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zofenopril"],"crossReferences":{"PubChem":["50112709"],"Wikipedia":["Zofenopril"],"drugbank":["DB13166"],"chEBI":["78539"]},"childChemblIds":["CHEMBL2105776"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL331743","canonicalSmiles":"CCOC(=S)SSC(=S)OCC","inchiKey":"FVIGODVHAVLZOO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIXANTHOGEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diethyldixanthogen","Diexanthogen","Dixanthogen","NSC-402561"],"crossReferences":{"PubChem":["144212544","29216271"],"Wikipedia":["Dixanthogen"],"drugbank":["DB13712"],"chEBI":["82241"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3334824","canonicalSmiles":"CC(C)[C@@H](NC(=O)NCC(C)(C)O)C(=O)N1CC[C@](O)(c2ccc(Cl)cc2)C(C)(C)C1","inchiKey":"GTDPZONCGOCXOD-JPYJTQIMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-817399","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-817399","Bms-817399"],"crossReferences":{"drugbank":["DB14941"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3526325","canonicalSmiles":"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncn[14c](Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cc1ccc(S(=O)(=O)O)cc1.O","inchiKey":"DFHHLTRPIUJKPY-RFYGMFIQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3526325","maximumClinicalTrialPhase":0,"parentId":"CHEMBL554","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3527103","canonicalSmiles":"COc1ccc2nc(COc3ccc(C[14CH]4SC(=O)NC4=O)cc3)n(C)c2c1.Cl","inchiKey":"LKKAMJRUPIIUTC-KXJXWDRPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3527103","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2104753","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544906","canonicalSmiles":"C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1.Cl","inchiKey":"ANFSNXAXVLRZCG-RSAXXLAASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZPHETAMINE HYDROCHLORIDE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3545985","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benzphetamine hydrochloride","Didrex"],"synonyms":["Benzphetamine chloride","Benzphetamine hydrochloride"],"crossReferences":{"DailyMed":["benzphetamine%20hydrochloride"],"chEBI":["59169"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960."}
{"id":"CHEMBL3544932","canonicalSmiles":"CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1","inchiKey":"WKDACQVEJIVHMZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAK-901","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tak-901"],"crossReferences":{"drugbank":["DB12756"]},"count":9,"linkedTargets":{"rows":["ENSG00000178999"],"count":1},"linkedDiseases":{"rows":["EFO_0002430","EFO_0009441","EFO_0000198","MONDO_0044903","EFO_0000095","EFO_0000574","EFO_0000222","EFO_0001378"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL3545073","drugType":"Small molecule","blackBoxWarning":false,"name":"AMA0076","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ama0076"],"count":2,"linkedTargets":{"rows":["ENSG00000134318","ENSG00000067900"],"count":2},"linkedDiseases":{"rows":["EFO_1001069","EFO_0000516"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545131","drugType":"Antibody","blackBoxWarning":false,"name":"ISATUXIMAB","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sarclisa"],"synonyms":["Isatuximab","Isatuximab-irfc","SAR-650984","SAR650984"],"crossReferences":{"DailyMed":["isatuximab-irfc"]},"count":11,"approvedIndications":["EFO_0001378"],"linkedTargets":{"rows":["ENSG00000004468"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003073","EFO_0000203","EFO_0005592","EFO_0000220","EFO_0001642","MONDO_0044917","EFO_0000574","EFO_0000222","EFO_0001378","EFO_1001264","EFO_0000540","EFO_1001951"],"count":13},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for multiple myeloma and has 10 investigational indications."}
{"id":"CHEMBL3545209","drugType":"Small molecule","blackBoxWarning":false,"name":"NKTR-171","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nktr-171"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545229","drugType":"Small molecule","blackBoxWarning":false,"name":"DWP05195","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dwp05195"],"linkedTargets":{"rows":["ENSG00000196689"],"count":1},"linkedDiseases":{"rows":["EFO_0006510"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545263","drugType":"Small molecule","blackBoxWarning":false,"name":"LGX-806","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lgx-806","NVP-LGX806"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545413","canonicalSmiles":"Cc1ncc(NC(=O)c2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cccnc2)n1","inchiKey":"BJCJYEYYYGBROF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUMATINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Flumatinib","HH-GV678","Hhgv-678"],"crossReferences":{"drugbank":["DB11904"]},"childChemblIds":["CHEMBL3901539"],"count":1,"linkedTargets":{"rows":["ENSG00000097007"],"count":1},"linkedDiseases":{"rows":["EFO_0000339","EFO_0000220"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL355497","canonicalSmiles":"Cc1c(C(=O)c2nccn2C)oc2cccc(OCCCNCc3cccnc3)c12","inchiKey":"VZBQJKIOAOUYJL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL355497","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03062"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3616752","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)C(C)C","inchiKey":"DLSWIYLPEUIQAV-CCUURXOWSA-N","drugType":"Unknown","blackBoxWarning":false,"name":"CHEMBL3616752","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13928"]},"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3622533","canonicalSmiles":"COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1","inchiKey":"JOWXJLIFIIOYMS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FIMEPINOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CUDC-907","CUDC907","Cudc 907","Cudc-907","Fimepinostat"],"crossReferences":{"drugbank":["DB11891"]},"count":2,"linkedTargets":{"rows":["ENSG00000094631","ENSG00000061273","ENSG00000051382","ENSG00000163517","ENSG00000068024","ENSG00000196591","ENSG00000108840","ENSG00000171608","ENSG00000147099","ENSG00000116478","ENSG00000100429","ENSG00000121879","ENSG00000171720","ENSG00000048052"],"count":14},"linkedDiseases":{"rows":["MONDO_0044889","EFO_0005783","MONDO_0002108","EFO_0000574"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707221","canonicalSmiles":"CCCC[C@]1(CC)CS(=O)(=O)c2ccc(N(C)C)cc2[C@@H](c2cccc(NC(=O)N[C@@H]3O[C@H](COS(=O)(=O)[O-])[C@@H](O)[C@H](OCc4ccccc4)[C@H]3O)c2)[C@H]1O.[K+]","inchiKey":"CJMKTEIIPMBTJB-DXFHJFHKSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"VOLIXIBAT POTASSIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3707222","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LUM002","Volixibat potassium"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707352","drugType":"Small molecule","blackBoxWarning":false,"name":"POLICOSANOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Policosanol"],"crossReferences":{"DrugCentral":["5074"]},"count":1,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL37537","canonicalSmiles":"O=C(O)c1ccc(O)c(O)c1","inchiKey":"YQUVCSBJEUQKSH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROTOCATECHUIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Protacatechuic Acid"],"crossReferences":{"PubChem":["144207365","26665736"],"Wikipedia":["Protocatechuic_acid"],"drugbank":["DB03946"],"chEBI":["36062"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL379367","canonicalSmiles":"NC(=O)c1c(NC(=O)C2CC2)sc2c1CCCC2","inchiKey":"VATFNEMGBRWLHI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL379367","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07398"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL379630","canonicalSmiles":"N[C@H](Cc1ccccc1)C(=O)O","inchiKey":"COLNVLDHVKWLRT-MRVPVSSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-PHENYLALANINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26756693"],"drugbank":["DB02556"],"chEBI":["16998"]},"childChemblIds":["CHEMBL4303563"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL382639","canonicalSmiles":"CCOc1nc(NC(=O)Cc2cc(OC)c(Br)cc2OC)cc(N)c1C#N","inchiKey":"GKODDLYLEKSDJL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL382639","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07272"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833384","drugType":"Protein","blackBoxWarning":false,"name":"EFLAPEGRASTIM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eflapegrastim","HM-10460A","HM10460A","HNK-460","HNK460","SPI-2012","SPL-2012"],"count":2,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3894860","canonicalSmiles":"CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1","inchiKey":"PDGKHKMBHVFCMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRILACICLIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["G1T28","Trilaciclib"],"crossReferences":{"drugbank":["DB15442"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3922781","canonicalSmiles":"C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1.Cl","inchiKey":"LTXZPEXBCOGOAG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3922781","maximumClinicalTrialPhase":0,"parentId":"CHEMBL598797","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL396380","canonicalSmiles":"N[C@@H](CO)[C@@H](O)[C@H](O)[C@H](O)COP(=O)(O)O","inchiKey":"LBNVXZROMBUNNQ-SLPGGIOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL396380","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02445"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989551","canonicalSmiles":"CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1.Cl.O","inchiKey":"LFZGYTBWUHCAKF-DCNJEFSFSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LINCOMYCIN HYDROCHLORIDE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1447","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lincocin","Lincomycin hydrochloride"],"synonyms":["Lincolnensin hydrochloride monohydrate","Lincomycin hydrochloride","Lincomycin hydrochloride anhdrous","Lincomycin hydrochloride hydrate","Lincomycin hydrochloride monohydrate","NSC-70731"],"crossReferences":{"DailyMed":["lincomycin%20hydrochloride"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1964 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989676","canonicalSmiles":"CCCCC1C(=O)N(c2ccccc2)N(c2ccc(O)cc2)C1=O.O","inchiKey":"CNDQSXOVEQXJOE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYPHENBUTAZONE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1228","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"," Germany"," France"],"classes":["Dermatological toxicity"," Hematological toxicity"],"year":1984},"tradeNames":["Oxyphenbutazone","Tandearil","Tanderil","Tanderil chloramphen"],"synonyms":["Oxazolidin","Oxiphenbutazone","Oxyphenbutazone"],"count":4,"approvedIndications":["HP_0002829","HP_0003326","EFO_0005755","EFO_0005752"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["HP_0002829","HP_0003326","EFO_0005755","EFO_0005752"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and has 4 approved indications. It was withdrawn in United Kingdom,  United States,  Germany and  France initially in 1984 due to Dermatological toxicity and  Hematological toxicity."}
{"id":"CHEMBL3989909","canonicalSmiles":"CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1.O=P(O)(O)O","inchiKey":"XXEDEGOAYSGNPS-ZOWNYOTGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LENIOLISIB PHOSPHATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3643413","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CDZ-173","CDZ-173-AZ","CDZ173","CDZ173-AZ","Cdz173","Leniolisib phosphate"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3989910","canonicalSmiles":"O=C(O)c1ccc(-c2ccc3cc(O)ccc3n2)c(Cl)c1","inchiKey":"BXSZILNGNMDGSL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAVOSONSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cavosonstat","N-91115","N91115"],"crossReferences":{"drugbank":["DB14775"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4105484","canonicalSmiles":"[2H]C([2H])([2H])NC(=O)c1ccc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F","inchiKey":"HJBWBFZLDZWPHF-FIBGUPNXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4105484","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3183409","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL412262","canonicalSmiles":"CN/C(=N\\S(=O)(=O)c1ccc(Cl)cc1)N1C[C@H](c2ccccc2)C(c2ccc(Cl)cc2)=N1","inchiKey":"AXJQVVLKUYCICH-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBIPINABANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-646256","Ibipinabant","SLV-319","Slv319"],"crossReferences":{"drugbank":["DB12649"]},"count":2,"linkedTargets":{"rows":["ENSG00000118432"],"count":1},"linkedDiseases":{"rows":["EFO_0001360","EFO_0001073"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL412763","canonicalSmiles":"NCCCNCCO[C@H]1[C@H](O[C@@H]2[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2N)O[C@H](CO)[C@H]1O[C@H]1O[C@@H](CN)[C@@H](O)[C@H](O)[C@H]1N","inchiKey":"FJVLHNJZMYGVLT-XXJRHLBLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL412763","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04717"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL425252","canonicalSmiles":"Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)n1","inchiKey":"ZWIADYZPOWUWEW-XVFCMESISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL425252","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Cytidine_diphosphate"],"drugbank":["DB04555"],"chEBI":["17239"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297218","canonicalSmiles":"CCOC(=O)Cn1nc(C(F)(F)F)cc1-c1ccc(-c2cccc(S(C)(=O)=O)c2)cc1","inchiKey":"ZUMNJDGBYXHASJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROVAZOLAC","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALX-101","Rovazolac"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297319","canonicalSmiles":"CN1CC2CCCC(C1)C2OC(=O)C(O)(c1ccccc1)C1CCCC1.Cl","inchiKey":"AUKYHFFECJXLHI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENCYNONATE HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4299850","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phencynonate hydrochloride"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297346","canonicalSmiles":"COc1ccc2c(c1)nc([S+]([O-])Cc1ncc(C)c(OC)c1C)n2S(=O)(=O)c1ccc(OCC(=O)O)cc1","inchiKey":"PPCGSVWOZKNPCX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AGN-201904","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGN 201904","Agn 201904","Agn-201904"],"crossReferences":{"drugbank":["DB13135"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297456","canonicalSmiles":"CC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(N)=O","inchiKey":"MMHDBUJXLOFTLC-WOYTXXSLSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ATN-161","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATN 161","ATN-161","Atn-161"],"count":2,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297530","canonicalSmiles":"CCO[C@@H](Cc1ccc(OCCn2c(C)ccc2-c2ccc(SC)cc2)cc1)C(=O)O","inchiKey":"MRWFZSLZNUJVQW-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAROGLITAZAR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Saroglitazar"],"crossReferences":{"drugbank":["DB13115"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297533","canonicalSmiles":"CC(=O)O.CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC1=O","inchiKey":"MAYUSRUHXFWITM-GBRHMYBBSA-N","drugType":"Protein","blackBoxWarning":false,"name":"BREMELANOTIDE ACETATE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2070241","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vyleesi (autoinjector)"],"synonyms":["Bremelanotide acetate","PT 141","PT-141"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 2019."}
{"id":"CHEMBL4297707","drugType":"Unknown","blackBoxWarning":false,"name":"BMS-986207","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-986207"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297772","drugType":"Unknown","blackBoxWarning":false,"name":"INTERLEUKIN-7","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CYT107","Cyt 107","Cyt107","Interleukin 7","Interleukin-7"],"count":13,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 13 investigational indications."}
{"id":"CHEMBL4298037","drugType":"Antibody","blackBoxWarning":false,"name":"RETIFANLIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AEX-1188","AEX1188","INCMGA-00012","INCMGA-0012","INCMGA00012","Incmga00012","MGA-012","MGA012","Mga-012","Mga012","Retifanlimab"],"count":8,"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL4298128","canonicalSmiles":"Cc1nn(C)cc1S(=O)(=O)NC(=O)c1ccc(-n2ccc(OCC(C)(C)C(F)(F)F)n2)nc1N1C[C@@H](C)CC1(C)C","inchiKey":"MVRHVFSOIWFBTE-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELEXACAFTOR","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["3-PYRIDINECARBOXAMIDE, N-((1,3-DIMETHYL-1H-PYRAZOL-4-YL)SULFONYL)-6-(3-(3,3,3-TRIFLUORO-2,2-DIMETHYLPROPOXY)-1H-PYRAZOL-1-YL)-2-((4S)-2,2,4-TRIMETHYL-1-PYRROLIDINYL)-","Elexacaftor","VX-445","Vx-445"],"crossReferences":{"drugbank":["DB15444"]},"count":1,"linkedTargets":{"rows":["ENSG00000001626"],"count":1},"linkedDiseases":{"rows":["Orphanet_586"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2019 and has 1 investigational indication."}
{"id":"CHEMBL4303782","canonicalSmiles":"COc1cc2c(c(OC)n1)[C@]1(O)[C@H](O)[C@H](CN(C)C)[C@@H](c3ccccc3)[C@]1(c1ccc(C#N)cc1)O2","inchiKey":"QYCXWOACFWMQFO-WZWZCULESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOTATIFIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EFT-226","EFT226","Eft226","Zotatifin"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL436546","canonicalSmiles":"CC(C)c1c(Cc2ccccc2)n(COCc2ccccc2)c(=O)[nH]c1=O","inchiKey":"KSAAUHMSLCPIEX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TNK-651","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TNK-651"],"crossReferences":{"drugbank":["DB08634"],"chEBI":["45910"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL445304","canonicalSmiles":"Nc1c(O)cccc1C(=O)O","inchiKey":"WJXSWCUQABXPFS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-Hydroxyanthranilic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Hydroxyanthranilic Acid"],"crossReferences":{"PubChem":["47193877"],"Wikipedia":["3-Hydroxyanthranilic_acid"],"drugbank":["DB03644"],"chEBI":["15793"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL45029","canonicalSmiles":"CCC1(c2ccccc2)C(=O)NC(=O)N(C)C1=O","inchiKey":"ALARQZQTBTVLJV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPHOBARBITAL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mebaral","Menta-bal","Prominal"],"synonyms":["Enphenemal","Mephobarbital","Methylphenobarbital","Methylphenobarbitone"],"crossReferences":{"PubChem":["144205153","29215275"],"Wikipedia":["Methylphenobarbital"],"drugbank":["DB00849"],"chEBI":["6758"]},"count":1,"approvedIndications":["EFO_0000474"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for epilepsy."}
{"id":"CHEMBL4543601","canonicalSmiles":"CN[C@H]1[C@@H](O)[C@@H](NC)[C@H](O)[C@H]2O[C@@H]3O[C@H](C)CC(=O)[C@]3(O)O[C@H]12.Cl.Cl.Cl.O.O.O","inchiKey":"QXDSXECEIXPAMK-LGSTXWLCSA-N","drugType":"unknown","blackBoxWarning":false,"name":"CHEMBL4543601","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1167","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594242","drugType":"Protein","blackBoxWarning":false,"name":"CALCITONIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calcimar","Calcitare","Calsynar","Cibacalcin","Forcaltonin","Fortical","Miacalcic"],"synonyms":["Calcitonin"],"count":3,"linkedTargets":{"rows":["ENSG00000004948"],"count":1},"linkedDiseases":{"rows":["EFO_0003931","EFO_1000950","EFO_0003854","MONDO_0002123","EFO_0003843","EFO_0004705"],"count":6},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594478","drugType":"Gene","blackBoxWarning":false,"name":"INODIFTAGENE VIXTEPLASMID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Inodiftagene vixteplasmid"],"count":1,"description":"Gene drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594508","drugType":"Unknown","blackBoxWarning":false,"name":"TRPH-222","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TRPH-222","Trph-222"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594595","drugType":"Unknown","blackBoxWarning":false,"name":"REGN-4018","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["REGN-4018","REGN4018","Regn-4018","Regn4018"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594609","drugType":"Unknown","blackBoxWarning":false,"name":"SR-123781A","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SANORG-123781","SR-123781","SR-123781A","SR123781A","Sr-123781a","Sr123781a"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL460785","canonicalSmiles":"Cl.OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"ZJIHMALTJRDNQI-VFQQELCFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DUVOGLUSTAT HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL307429","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AT-2220","AT2220","Duvoglustat hydrochloride"],"count":1,"linkedTargets":{"rows":["ENSG00000171298"],"count":1},"linkedDiseases":{"rows":["Orphanet_365"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL487738","canonicalSmiles":"NS(=O)(=O)c1ccc(Nc2cncc(Cl)n2)cc1","inchiKey":"RSNSGNZRUMHXAY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL487738","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08134"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL505851","canonicalSmiles":"CCC1(C2=CC3CCC(C2)C3)C(=O)NC(=O)NC1=O","inchiKey":"MKELYWOVSPVORM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REPOSAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Reposal"],"crossReferences":{"Wikipedia":["Reposal"],"drugbank":["DB13805"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL507361","canonicalSmiles":"O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F","inchiKey":"SUDAHWBOROXANE-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIRDAMETINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mirdametinib","PD-0325901","Pd 0325901","Pd-0325901"],"crossReferences":{"PubChem":["144206915"],"drugbank":["DB07101"],"chEBI":["88249"]},"count":5,"linkedTargets":{"rows":["ENSG00000126934","ENSG00000169032"],"count":2},"linkedDiseases":{"rows":["Orphanet_636","EFO_0003060","EFO_1001951","EFO_0000311"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL517944","canonicalSmiles":"CCCCCOc1ccc2cc(S(=O)(=O)N[C@H](CCC(=O)O)C(=O)O)ccc2c1","inchiKey":"LIGACKDHLKEZFH-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL517944","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08107"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL525076","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O","inchiKey":"PEASPLKKXBYDKL-FXEVSJAOSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ENFUVIRTIDE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fuzeon","Fuzeon T-20"],"synonyms":["DP-178","DP178","Enfuvirtide","Fuzeon","Pentafuside (trivial name)","T-20","T20"],"crossReferences":{"DailyMed":["enfuvirtide"],"Wikipedia":["Enfuvirtide"],"chEBI":["608828"]},"childChemblIds":["CHEMBL4085102"],"count":3,"approvedIndications":["EFO_0000764","EFO_0000763"],"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for viral disease and hiv infection and has 1 investigational indication."}
{"id":"CHEMBL533849","canonicalSmiles":"COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1.Cl","inchiKey":"KVBQCJXMSFJOFP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TCMDC-123476","maximumClinicalTrialPhase":0,"parentId":"CHEMBL24828","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TCMDC-123476"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL535166","canonicalSmiles":"Cl.NCCc1c[nH]cn1","inchiKey":"IVCJGQQPPHYHBS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HISTAMINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL90","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Histamine Dihydrochloride"],"crossReferences":{"PubChem":["8139934"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL535396","canonicalSmiles":"CC(N)C12CC3CC(CC(C3)C1)C2.Cl","inchiKey":"OZBDFBJXRJWNAV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIMANTADINE HYDROCHLORIDE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL959","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Flumadine","Meradan","Rimantadine hydrochloride","Roflual"],"synonyms":["EXP 126","EXP-126","NSC-206764","Rimantadine hydrochloride"],"crossReferences":{"DailyMed":["rimantadine%20hydrochloride"],"PubChem":["144205265","170465164","26661904"],"chEBI":["8865"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1993."}
{"id":"CHEMBL539934","canonicalSmiles":"C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N1)C(N)=O","inchiKey":"SNAJPQVDGYDQSW-DYCFWDQMSA-N","drugType":"Protein","blackBoxWarning":false,"name":"TT-232","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TLN-232","Tln-232","Tt-232"],"crossReferences":{"drugbank":["DB12088"]},"count":1,"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL544227","canonicalSmiles":"CC1(C)N=C(N)N=C(N)N1c1ccc(Cl)cc1.Cl","inchiKey":"MOUAPRKJJUXEIE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORCYCLOGUANIL HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL747","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GNF-Pf-2519"],"crossReferences":{"PubChem":["144207152"],"chEBI":["79772"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL553","canonicalSmiles":"C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1","inchiKey":"AAKJLRGGTJKAMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERLOTINIB","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tarceva"],"synonyms":["CP-358,774","CP-358774","CP-35877401","Erlotinib","OSI-774","R-1415","RG-1415","Ro-508231"],"crossReferences":{"DailyMed":["erlotinib%20hydrochloride"],"PubChem":["103905339","124893165","124893166","144205755","170465434","26757996","50100099","85267493"],"Wikipedia":["Erlotinib"],"drugbank":["DB00530"],"chEBI":["114785"]},"childChemblIds":["CHEMBL1079742"],"count":64,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0000691","MONDO_0003060","EFO_0000365","EFO_0000571","EFO_0000681","MONDO_0045056","EFO_0000756","EFO_1000657","EFO_0000308","EFO_1001951","EFO_0000565","EFO_0000588","MONDO_0002974","MONDO_0003268","Orphanet_733","MONDO_0008903","EFO_0000182","MONDO_0018531","MONDO_0020634","EFO_0000676","EFO_0000514","EFO_0007243","EFO_1000028","EFO_0000198","EFO_0002618","EFO_0003893","MONDO_0008170","EFO_0000349","MONDO_0044881","EFO_0002429","MONDO_0008315","EFO_0009708","EFO_1000026","MONDO_0002691","EFO_0005567","EFO_0001422","EFO_0003868","EFO_0005537","EFO_0000233","EFO_0006544","EFO_0001378","EFO_1000142","EFO_1000172","EFO_0000292","EFO_0005577","EFO_1001901","MONDO_0015686","MONDO_0021117","EFO_1001465","MONDO_0007254","EFO_0000708","MONDO_0021063","MONDO_0002087","EFO_0004252","EFO_0000305","MONDO_0001187","MONDO_0016691","EFO_1001480","EFO_1000044","MONDO_0002158","EFO_0003860","MONDO_0002898","MONDO_0001657","EFO_0002499","EFO_0000707","MONDO_0003478","EFO_1000158","EFO_0000616","EFO_0006859","Orphanet_523","EFO_0002916","MONDO_0007576","EFO_0000313","MONDO_0000521","EFO_0002501","EFO_0000222","EFO_0003060","EFO_0000311","EFO_0000640","MONDO_0016693","EFO_0004220","MONDO_0002529","EFO_1000581","EFO_0010282","MONDO_0011962","MONDO_0002367","EFO_0003833","MONDO_0024880","EFO_0000519","EFO_0000181","EFO_0003050","MONDO_0021637","MONDO_0044926"],"count":93},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for cancer and neoplasm and has 62 investigational indications."}
{"id":"CHEMBL55643","drugType":"Small molecule","blackBoxWarning":false,"name":"COPPER","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cu-7","Paragard t 380a","Tatum-t"],"synonyms":["Copper"],"crossReferences":{"DailyMed":["copper"],"chEBI":["29036"]},"count":7,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL562","canonicalSmiles":"COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O","inchiKey":"DDUHZTYCFQRHIY-RBHXEPJQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GRISEOFULVIN","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fulcin","Fulcin 125","Fulcin 500","Fulsovin","Fulvicin","Fulvicin p/g","Fulvicin p/g 165","Fulvicin p/g 330","Fulvicin-p/g","Fulvicin-u/f","Grifulvin","Grifulvin v","Gris-peg","Grisactin","Grisactin ultra","Griseofulvin","Griseofulvin, ultramicrosize","Griseofulvin,ultramicrosize","Grisol af","Grivate","Ultragris-165","Ultragris-330"],"synonyms":["Griseofulvin","Griseofulvin permeability diameter","Griseofulvin, microcrystalline","Griseofulvin, microsize","Griseofulvin, ultramicrocrystalline","Griseofulvin, ultramicrosize","NSC-34533"],"crossReferences":{"DailyMed":["griseofulvin,%20microsize","griseofulvin,%20ultramicrosize"],"PubChem":["144204638","144209433","144213322","170465739","17389865","26747301","50085968"],"TG-GATEs":["43"],"Wikipedia":["Griseofulvin"],"drugbank":["DB00400"],"chEBI":["27779"]},"childChemblIds":["CHEMBL3794184"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1962 and has 1 investigational indication."}
{"id":"CHEMBL567","canonicalSmiles":"OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1","inchiKey":"RGCVKNLCSQQDEP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PERPHENAZINE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chlorpiprazine","Decentan","Fentazin","Perphenazine","Perphenazine Fendizoate","Trilafon","Trilafon-La"],"synonyms":["Etaperazine","NSC-150866","Perphenazine","Perphenazine fendizoate","Perphenazine maleate"],"crossReferences":{"DailyMed":["perphenazine"],"PubChem":["11111645","11111646","124881147","144203784","170464834","26747080","26747081","50100322","50104233","50104234","56422427","57287811","85231190","856006","90340948"],"Wikipedia":["Perphenazine"],"drugbank":["DB00850"],"chEBI":["8028"]},"count":7,"approvedIndications":["EFO_0005407","EFO_0000692"],"linkedTargets":{"rows":["ENSG00000149295"],"count":1},"linkedDiseases":{"rows":["EFO_0002610","MONDO_0002050","HP_0000726","EFO_0000677","EFO_0005407","EFO_0005230","EFO_0000692","EFO_0005411","HP_0000713"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1957 and is indicated for schizophrenia and psychosis and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL570","canonicalSmiles":"CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21","inchiKey":"XSCGXQMFQXDFCW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIFLUPROMAZINE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fluopromazine","Nivoman","Vesprin","Vetame"],"synonyms":["Fluopromazine","Triflupromazine"],"crossReferences":{"PubChem":["11111873","11111874","124881619","50100355","50104262","90341005"],"Wikipedia":["Triflupromazine"],"drugbank":["DB00508"],"chEBI":["9711"]},"childChemblIds":["CHEMBL1201102"],"count":1,"approvedIndications":["EFO_0005407"],"linkedTargets":{"rows":["ENSG00000149295"],"count":1},"linkedDiseases":{"rows":["EFO_0005407"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957 and is indicated for psychosis."}
{"id":"CHEMBL577294","canonicalSmiles":"CC(O)COC[C@H]1O[C@@H]2O[C@@H]3[C@@H](COCC(C)O)O[C@H](O[C@@H]4[C@@H](COCC(C)O)O[C@H](O[C@@H]5[C@@H](COCC(C)O)O[C@H](O[C@@H]6[C@@H](COCC(C)O)O[C@H](O[C@@H]7[C@@H](COCC(C)O)O[C@H](O[C@@H]8[C@@H](COCC(C)O)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O","inchiKey":"ODLHGICHYURWBS-LKONHMLTSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"2-HYDROXYPROPYL-BETA-CYCLODEXTRIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-hydroxypropyl-beta-cyclodextrin","Hydroxypropyl betadex","Hydroxypropyl-Beta-Cyclodextrin"],"count":2,"description":"Oligosaccharide drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL586702","canonicalSmiles":"FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1","inchiKey":"HGVNLRPZOWWDKD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TCMDC-137004","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TCMDC-137004"],"crossReferences":{"drugbank":["DB12904"],"chEBI":["90545"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL59030","canonicalSmiles":"O=C(O)Cc1cccc(OCCCN(Cc2cccc(C(F)(F)F)c2Cl)CC(c2ccccc2)c2ccccc2)c1","inchiKey":"NAXSRXHZFIBFMI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GW3965","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW3965"],"crossReferences":{"PubChem":["124892359","26755460"],"drugbank":["DB03791"],"chEBI":["79995"]},"childChemblIds":["CHEMBL4060455"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL592943","canonicalSmiles":"CCOC(=O)c1c(N)sc2c1CCN(Cc1ccccc1)C2","inchiKey":"PFENFDGYVLAFBR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TINORIDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-158555","Tinoridine","Tinoridine hydrochloride","Y 3642","Y-3642"],"crossReferences":{"PubChem":["124892200","144205231","170465864","17441321","29215397"],"drugbank":["DB13001"]},"childChemblIds":["CHEMBL4303244"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL593503","canonicalSmiles":"O=C(O)Cc1cc(=O)[nH]c(=O)[nH]1","inchiKey":"NQAUNZZEYKWTHM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Uracil-4-Acetic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Uracil-4-Acetic Acid"],"crossReferences":{"drugbank":["DB03048"],"chEBI":["46371"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL61441","canonicalSmiles":"O=C([O-])c1c(Cl)c(Cl)c(Cl)c(Cl)c1-c1c2cc(Br)c(=O)c(Br)c-2oc2c(Br)c([O-])c(Br)cc12.[Na+].[Na+]","inchiKey":"GVKCHTBDSMQENH-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL61441","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1205178","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13911"],"chEBI":["87192"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL76029","canonicalSmiles":"CC(C)(Oc1ccc(NC(=O)Nc2cc(Cl)cc(Cl)c2)cc1)C(=O)O","inchiKey":"OYJPTSMWFKGZJM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL76029","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08077"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL8483","canonicalSmiles":"CCCCCCCCCC(=O)CC(=O)N[C@H]1CCOC1=O","inchiKey":"PHSRRHGYXQCRPU-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N-(3-Oxododecanoyl)Homoserinelactone","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N-(3-Oxododecanoyl)Homoserinelactone"],"crossReferences":{"drugbank":["DB08324"],"chEBI":["44534"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL87493","canonicalSmiles":"CCNC(C)Cc1cccc(C(F)(F)F)c1","inchiKey":"DBGIVFWFUFKIQN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FENFLURAMINE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Cardiotoxicity"]},"tradeNames":[],"synonyms":["Fenfluramine","J5.760F","S-768","Z-008","Z008","ZX-008","ZX008"],"crossReferences":{"DailyMed":["fenfluramine%20hydrochloride"],"PubChem":["144205250","29215428"],"Wikipedia":["Fenfluramine"],"drugbank":["DB00574"],"chEBI":["5000"]},"childChemblIds":["CHEMBL2106217"],"count":4,"approvedIndications":["EFO_0001073"],"linkedTargets":{"rows":["ENSG00000179546","ENSG00000147955","ENSG00000147246"],"count":3},"linkedDiseases":{"rows":["EFO_0002610","Orphanet_33069","EFO_0000474","MONDO_0015643","MONDO_0100062","EFO_0001073"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for obesity and has 3 investigational indications. It was withdrawn in United States due to Cardiotoxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL919","canonicalSmiles":"O=C1NC(c2ccccc2)(c2ccccc2)C(=O)N1COP(=O)([O-])[O-].[Na+].[Na+]","inchiKey":"GQPXYJNXTAFDLT-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":true,"name":"FOSPHENYTOIN SODIUM","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201336","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cerebyx","Fosphenytoin sodium","Pro-epanutin"],"synonyms":["ACC-9653-010","ACC-9653-010 (SODIUM SALT)","CI-982","Fosphenytoin sodium"],"crossReferences":{"DailyMed":["fosphenytoin%20sodium"],"Wikipedia":["Fosphenytoin"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1996. This drug has a black box warning from the FDA."}
{"id":"CHEMBL93047","canonicalSmiles":"CCN1C(=O)OC(C)(C)C1=O","inchiKey":"SIGSNYAYBSJATD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHADIONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ethadione"],"crossReferences":{"Wikipedia":["Ethadione"],"drugbank":["DB13799"],"chEBI":["81296"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL940","canonicalSmiles":"NCC1(CC(=O)O)CCCCC1","inchiKey":"UGJMXCAKCUNAIE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GABAPENTIN","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gabapentin","Gralise","Neurontin"],"synonyms":["CI-945","DM-1796","GOE 3450","GOE-3450","Gabapentin"],"crossReferences":{"DailyMed":["gabapentin"],"PubChem":["104171164","11112806","11113327","124880194","144203708","170464715","50103936","855579","90340599"],"Wikipedia":["Gabapentin"],"drugbank":["DB00996"],"chEBI":["42797"]},"childChemblIds":["CHEMBL542620"],"count":54,"approvedIndications":["EFO_0000474"],"linkedTargets":{"rows":["ENSG00000153956"],"count":1},"linkedDiseases":{"rows":["HP_0000989","EFO_0004777","EFO_0003768","HP_0031217","EFO_0004698","EFO_0003829","EFO_0002506","EFO_0004263","EFO_1001898","EFO_1000632","EFO_0006510","HP_0003419","HP_0008419","EFO_0000692","EFO_1001250","EFO_0005762","EFO_0003756","HP_0000360","EFO_1000877","EFO_1001931","EFO_1000864","HP_0012532","EFO_1001255","EFO_0005323","MONDO_0022113","MONDO_0021374","MONDO_0008315","EFO_0000546","EFO_1002028","EFO_0001422","HP_0003401","EFO_0000270","EFO_0004888","MONDO_0018373","EFO_0003086","EFO_0000292","EFO_0005687","Orphanet_232","HP_0000726","MONDO_0007254","EFO_0009267","EFO_0007191","EFO_1000783","EFO_0000474","MONDO_0002050","EFO_0003100","EFO_0000279","EFO_0004143","HP_0002013","HP_0100749","EFO_0003917","EFO_0005230","EFO_0009625","EFO_0006859","HP_0001337","EFO_0004329","HP_0011110","EFO_0005407","HP_0001250","EFO_0003843","EFO_1000971","EFO_0000311","EFO_0008533","EFO_0009855","EFO_0003885","EFO_0003890","EFO_0000713","EFO_0000512","EFO_0004273","EFO_0005611","EFO_1001800","EFO_0004710"],"count":72},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for epilepsy and has 53 investigational indications."}
{"id":"CHEMBL979","canonicalSmiles":"CCCC(C)(COC(N)=O)COC(N)=O","inchiKey":"NPPQSCRMBWNHMW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPROBAMATE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amosene","Bamate","Equanil","Mepriam","Meprobamate","Meprospan","Miltown","Neuramate","Tenavoid","Tranmep"],"synonyms":["Meprobamate"],"crossReferences":{"DailyMed":["meprobamate"],"PubChem":["144204614","144207530","17389535"],"Wikipedia":["Meprobamate"],"drugbank":["DB00371"]},"count":1,"approvedIndications":["EFO_0005230"],"linkedTargets":{"rows":["ENSG00000022355","ENSG00000109158","ENSG00000145863","ENSG00000011677","ENSG00000151834","ENSG00000145864","ENSG00000186297","ENSG00000166206","ENSG00000163288"],"count":9},"linkedDiseases":{"rows":["EFO_0005230"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1955 and is indicated for anxiety."}
